Working group on musculoskeletal rehabilitation in patients with osteoporosis abstracts WG1–WG5
- Publisher
- American Society for Bone and Mineral Research
- Year
- 2003
- Tongue
- English
- Weight
- 24 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0884-0431
No coin nor oath required. For personal study only.
✦ Synopsis
Our 1 st Annual Working Group was held in San Francisco in December 1998 during the Joint Meeting of the American Society for Bone and Mineral Research (ASBMR) and International Bone and Mineral Society (IBMS). The Annual Meeting of the ASBMR provides a perfect setting for our Working Group since scientists, researchers and clinicians of various specialties from around the world attend the meeting. Here we can "link up" with our colleagues to join forces in resolving the issues confronting us in the overall management of osteoporosis by combining pharmacotherapy with non-pharmacotherapy and other rehabilitative options for proper management of osteoporosis.
The reduction of bone mass and the occurrence of osteoporotic fractures create specific musculoskeletal challenges that cannot be met with pharmacotherapy alone. Osteoporosis affects the "whole person" lifestyles change, quality of life declines and self-esteem suffers. As the skeletal frame shrinks and posture fails, osteoporotic individuals often suffer psychologically as well. They are afraid to participate in and enjoy physical activities for fear of fall or fracture.
The objectives of our Working Group are to address the musculoskeletal challenges of osteoporosis through education, exercise, therapeutic modalities for pain control, and technical devices for maintenance of posture and prevention of falls. Through our publications, clinicians can help their patients to adjust to the musculoskeletal challenges of osteoporosis and learn to alternate -not terminate their daily physical activities.
Although, some evidence-based studies are available on the efficacy of non-pharmacotherapy in the management of osteoporosis, further controlled trials are needed in this area. As core members of this Working Group, we are committed to the promotion of further controlled trials to confirm the benefits of non-pharmacotherapy in the management of osteoporosis. The core group is also committed to the publication of a review paper addressing the role of non-pharmacotherapy alone and/or combined with pharmacotherapy for prevention/management of osteoporosis.
WG2
Vitamin D and Musculoskeletal Disability in the Elderly. H.A. Bischoff.
📜 SIMILAR VOLUMES